Pascale Witz - 28 Apr 2023 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co

Role
Director
Signature
/s/ Meghanne Downes, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
28 Apr 2023
Net transactions value
-$208,870
Form type
4
Filing time
02 May 2023, 19:34:27 UTC
Previous filing
10 Jun 2022
Next filing
17 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Options Exercise +3,913 +27% 18,202 28 Apr 2023 Direct F1, F2
transaction HZNP Ordinary Shares Tax liability $208,870 -1,879 -10% $111.16 16,323 28 Apr 2023 Direct
holding HZNP Ordinary Shares 29,628 28 Apr 2023 By Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HZNP Restricted Stock Units Options Exercise $0 -3,913 -100% $0.000000* 0 28 Apr 2023 Ordinary Shares 3,913 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
F2 14,289 Ordinary Shares previously reported as indirectly held by Trust held directly.